See more : NextGen Healthcare, Inc. (NXGN) Income Statement Analysis – Financial Results
Complete financial analysis of Philip Morris International Inc. (PM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Philip Morris International Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- Alliance Entertainment Holding Corporation (AENTW) Income Statement Analysis – Financial Results
- EVO Transportation & Energy Services, Inc. (EVOA) Income Statement Analysis – Financial Results
- Raiffeisen Bank International AG (RAIFY) Income Statement Analysis – Financial Results
- Nextensa NV/SA (NEXTA.BR) Income Statement Analysis – Financial Results
- Maquia Capital Acquisition Corporation (MAQCW) Income Statement Analysis – Financial Results
Philip Morris International Inc. (PM)
About Philip Morris International Inc.
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.17B | 31.76B | 31.41B | 28.69B | 29.81B | 29.63B | 28.75B | 26.69B | 26.79B | 29.77B | 31.22B | 31.38B | 31.10B | 27.21B | 25.04B | 25.71B | 22.80B | 48.26B | 45.29B | 33.39B | 8.10B |
| Cost of Revenue | 12.89B | 11.23B | 10.03B | 9.57B | 10.51B | 10.76B | 10.43B | 9.39B | 9.37B | 10.44B | 10.41B | 10.37B | 10.68B | 9.71B | 9.02B | 9.33B | 8.72B | 35.62B | 32.92B | 23.82B | 2.81B |
| Gross Profit | 22.28B | 20.53B | 21.38B | 19.13B | 19.29B | 18.87B | 18.32B | 17.29B | 17.43B | 19.33B | 20.81B | 21.00B | 20.42B | 17.50B | 16.01B | 16.38B | 14.08B | 12.64B | 12.37B | 9.57B | 5.30B |
| Gross Profit Ratio | 63.35% | 64.65% | 68.06% | 66.65% | 64.73% | 63.69% | 63.71% | 64.81% | 65.05% | 64.94% | 66.65% | 66.94% | 65.66% | 64.30% | 63.96% | 63.71% | 61.75% | 26.19% | 27.31% | 28.66% | 65.36% |
| Research & Development | 709.00M | 642.00M | 617.00M | 495.00M | 465.00M | 383.00M | 453.00M | 429.00M | 423.00M | 433.00M | 449.00M | 415.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.11B | 8.14B | 8.52B | 7.48B | 8.78B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -148.00M | 8.30B | 7.38B | 8.70B | 7.41B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.11B | 7.99B | 8.30B | 7.41B | 8.17B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.96B | 6.88B | 6.16B | 5.87B | 6.00B | 5.02B | 4.57B | 4.54B | 3.37B | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -41.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.00M | 88.00M | 74.00M | 44.00M | 28.00M | 0.00 | 90.00M | 0.00 | 0.00 |
| Operating Expenses | 10.63B | 8.18B | 8.37B | 7.54B | 8.70B | 7.47B | 6.75B | 6.39B | 6.70B | 7.52B | 7.31B | 7.16B | 6.98B | 6.25B | 5.94B | 6.05B | 5.05B | 4.27B | 4.63B | 3.37B | 2.35B |
| Cost & Expenses | 23.62B | 19.40B | 18.40B | 17.11B | 19.21B | 18.23B | 17.19B | 15.78B | 16.07B | 17.96B | 17.72B | 17.53B | 17.66B | 15.96B | 14.97B | 15.37B | 13.77B | 39.89B | 37.55B | 27.19B | 5.16B |
| Interest Income | 465.00M | 180.00M | 109.00M | 110.00M | 226.00M | 190.00M | 182.00M | 178.00M | 124.00M | 118.00M | 131.00M | 148.00M | 134.00M | 98.00M | 108.00M | 217.00M | 0.00 | 229.00M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.53B | 768.00M | 737.00M | 728.00M | 570.00M | 665.00M | 914.00M | 891.00M | 1.13B | 1.17B | 1.10B | 1.01B | 800.00M | 974.00M | 797.00M | 528.00M | 10.00M | 371.00M | 94.00M | 0.00 | 146.00M |
| Depreciation & Amortization | 1.40B | 1.19B | 998.00M | 981.00M | 964.00M | 989.00M | 875.00M | 743.00M | 754.00M | 889.00M | 882.00M | 898.00M | 98.00M | 932.00M | 853.00M | 44.00M | 748.00M | 658.00M | 527.00M | 370.00M | 0.00 |
| EBITDA | 13.37B | 13.79B | 14.17B | 12.92B | 11.95B | 12.58B | 12.46B | 11.71B | 11.47B | 12.67B | 14.48B | 14.85B | 14.48B | 12.19B | 10.94B | 11.09B | 9.64B | 9.23B | 8.26B | 6.57B | 2.95B |
| EBITDA Ratio | 38.02% | 42.88% | 44.81% | 44.26% | 40.34% | 41.60% | 43.06% | 43.31% | 42.71% | 44.10% | 47.11% | 47.31% | 43.89% | 45.12% | 43.63% | 40.69% | 43.57% | 18.08% | 18.44% | 19.67% | 36.36% |
| Operating Income | 12.70B | 12.54B | 13.08B | 11.72B | 11.06B | 11.34B | 11.50B | 10.82B | 10.69B | 12.24B | 13.82B | 13.95B | 13.33B | 11.20B | 10.04B | 10.25B | 8.87B | 8.37B | 7.74B | 6.20B | 2.95B |
| Operating Income Ratio | 36.10% | 39.49% | 41.64% | 40.84% | 37.10% | 38.26% | 40.01% | 40.53% | 39.90% | 41.11% | 44.28% | 44.45% | 42.87% | 41.16% | 40.10% | 39.87% | 38.92% | 17.34% | 17.08% | 18.56% | 36.36% |
| Total Other Income/Expenses | -2.09B | -773.00M | -695.00M | -751.00M | -1.04B | -605.00M | -855.00M | -797.00M | -971.00M | -947.00M | -995.00M | -959.00M | -810.00M | -876.00M | -797.00M | -311.00M | -49.00M | -124.00M | -94.00M | 17.00M | -179.00M |
| Income Before Tax | 10.61B | 11.77B | 12.38B | 10.97B | 10.02B | 10.73B | 10.65B | 10.02B | 9.72B | 10.76B | 12.52B | 12.99B | 12.53B | 10.32B | 9.24B | 9.94B | 8.86B | 8.23B | 7.64B | 6.21B | 2.77B |
| Income Before Tax Ratio | 30.16% | 37.06% | 39.42% | 38.23% | 33.62% | 36.22% | 37.04% | 37.54% | 36.28% | 36.13% | 40.11% | 41.39% | 40.30% | 37.94% | 36.92% | 38.66% | 38.88% | 17.05% | 16.87% | 18.61% | 34.16% |
| Income Tax Expense | 2.34B | 2.24B | 2.67B | 2.38B | 2.29B | 2.45B | 4.31B | 2.77B | 2.69B | 3.10B | 3.67B | 3.83B | 3.65B | 2.83B | 2.69B | 2.79B | 2.56B | 1.83B | 1.84B | 2.09B | 593.00M |
| Net Income | 7.79B | 9.05B | 9.11B | 8.06B | 7.19B | 7.91B | 6.04B | 6.97B | 6.87B | 7.49B | 8.58B | 8.80B | 8.59B | 7.26B | 6.34B | 6.89B | 6.03B | 6.15B | 5.62B | 3.98B | 2.23B |
| Net Income Ratio | 22.15% | 28.49% | 29.00% | 28.08% | 24.11% | 26.70% | 20.99% | 26.11% | 25.65% | 25.17% | 27.47% | 28.05% | 27.63% | 26.68% | 25.33% | 26.80% | 26.43% | 12.74% | 12.41% | 11.91% | 27.50% |
| EPS | 5.02 | 5.82 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.93 | 3.25 | 3.33 | 2.86 | 2.91 | 2.71 | 1.96 | 1.34 |
| EPS Diluted | 5.02 | 5.81 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.92 | 3.24 | 3.32 | 2.86 | 2.91 | 2.69 | 1.95 | 1.34 |
| Weighted Avg Shares Out | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.94B | 2.07B | 2.11B | 2.11B | 2.07B | 2.03B | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.95B | 2.08B | 2.11B | 2.11B | 2.09B | 2.04B | 0.00 |
Philip Morris Hits Record High on Q3 Earnings Beat: ETFs in Focus
Look at ETFs with exposure to Philip Morris, as the tobacco giant beats earnings estimates and surges to a record high.
5 High-Yield Dividend Stocks to Buy Without Hesitation
These five dividend powerhouses offer yields above 4%.
Philip Morris' Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands
Stifel analyst Matthew E. Smith reiterated a Buy rating on Philip Morris International Inc PM, raising the price forecast to $145 from $138.
Philip Morris Stock Moves Into Buy Zone After Earnings Surprise
A recent double-digit move for Philip Morris stock was strong enough to help it break out of a cup base and surpass a 128.22 buy point.
Philip Morris International Pops; Yield Drops
PM reported its eleventh earnings triple play in its history and the first since February 2023. Given the size of yesterday's move higher, PM's dividend yield dropped from 4.54% on Monday to 4.15% on Tuesday. While PM's yield is down...
Philip Morris (PM) is an Incredible Growth Stock: 3 Reasons Why
Philip Morris (PM) possesses solid growth attributes, which could help it handily outperform the market.
Huge sales of the nicotine patch Zyn have sent Philip Morris's stock to an all-time high
Philip Morris International stock surged 10% after strong Q3 revenue and profit guidance. Zyn nicotine pouch sales grew 41% in the US in the third quarter.
Philip Morris' Raised Guidance Suggests Good Visibility: Goldman Sachs Analyst
On Tuesday, Philip Morris International Inc. PM reported third-quarter revenue of $9.91 billion, up 8.4% year over year, beating the consensus of $9.69 billion.
Record Earnings: Should Investors Buy Philip Morris Stock Now?
Philip Morris International ( PM ) has quietly been one of the best performing stocks in the market over the last three months. This strong outperformance comes after several years of sideways action in the stock as tobacco stocks fell...
Philip Morris is a growth stock again as shares hit all-time high on Zyn demand boom
The company's stock was tracking for a record close and clinched a fresh intraday record.
Source: https://incomestatements.info
Category: Stock Reports